Cost-effectiveness of precision medicine in oncology setting in China: protocol for a systematic review and meta-analysis
Introduction The past decade has witnessed significant advancements in genome-targeted oncology drugs within the realm of precision medicine (PM). However, the cost-effectiveness of oncology PM in a highly populated, low- and middle-income country such as China remains uncertain, particularly due to...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/7/e093416.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|